Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Avapritinib. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN111454217A details a green Rh-catalyzed route for Avapritinib intermediates, offering safer chiral induction and scalable manufacturing for global supply chains.
Patent CN111471020B reveals a novel Rh-catalyzed route for Avapritinib intermediates, offering safer conditions and reduced costs for reliable API manufacturing.
Patent CN110950872A details a high-yield Boc-protection strategy for Avapritinib, offering cost reduction in API manufacturing and enhanced supply chain reliability.